Paul Gallagher
Glasgow, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial.
Journal: Health technology assessment (Winchester, England)
Published: June 29, 2026
The 2024 McDonald criteria for the diagnosis of multiple sclerosis: implications for clinical practice.
Journal: Practical neurology
Published: April 28, 2026
Approach to JCV testing with natalizumab biosimilar: a UK consensus statement.
Journal: Multiple sclerosis and related disorders
Published: March 24, 2025
Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial.
Journal: Lancet (London, England)
Published: March 23, 2025
Acute sensorimotor paraneoplastic neuropathy in a patient with small cell prostate cancer.
Journal: BMJ case reports
Published: February 28, 2024
Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS).
Journal: Multiple sclerosis and related disorders
Published: March 08, 2022
The reliability and validity of DSM 5 diagnostic criteria for neurocognitive disorder and relationship with plasma neurofilament light in a down syndrome population.
Journal: Scientific reports
Published: January 22, 2021
Prevalence, management, and outcomes of SARS-CoV-2 infections in older people and those with dementia in mental health wards in London, UK: a retrospective observational study.
Journal: The lancet. Psychiatry
Published: August 28, 2020
Last Updated: 09/26/2026